A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: vepdegestrant|DRUG: PF-07220060
Sponsor: Pfizer
Collaborators: Arvinas Estrogen Receptor, Inc.